• Vernakalant Hydrochloride: Assay Design Guide

  2026-09-03

  This scenario-based guide explains how to use Vernakalant Hydrochloride (SKU A3915) in ion-channel and cell viability workflows without confusing electrophysiological activity with nonspecific cytotoxicity. It covers concentration selection, solvent controls, orthogonal readouts, data interpretation, and practical supplier comparison.

• Naloxone Hydrochloride: A Mechanism-First Guide

  2026-09-03

  Explore how Naloxone hydrochloride functions as an opioid receptor antagonist across receptor-dependent and receptor-independent assays. This mechanism-first guide connects opioid signaling, neural stem cell proliferation modulation, immune studies, and rigorous experimental controls.

• Sulfo-NHS-Biotin: Chemistry, Controls, and Assay Design

  2026-09-02

  Sulfo-NHS-Biotin is a water-soluble amine-reactive reagent for controlled protein and cell-surface labeling. This guide connects its reaction chemistry with assay design and explains when random chemical biotinylation should give way to site-specific AviTag/BirA strategies.

• Suhuang, ER Stress, and NLRP3 in Cough Variant Asthma

  2026-09-02

  The reference study shows that Suhuang antitussive capsule protects against pulmonary dysfunction in an ovalbumin-induced cough variant asthma model by suppressing endoplasmic reticulum stress and downstream NLRP3 inflammasome activation. Its key mechanistic contribution is the proposed connection between calcium trafficking, PKCε, TXNIP, the RIP1–RIP3–Drp1 pathway, and inflammatory caspase-1 signaling.

• WP1066: Mapping JAK2/STAT3 Across Cancer and Repair

  2026-09-01

  WP1066 is more than a pathway inhibitor: it is a cell-permeable pharmacological counterprobe for determining when JAK2/STAT3 signaling drives malignant persistence or supports reparative macrophage function. This article connects cancer biology, renal carcinoma and AML models with emerging biomaterial research while defining practical validation strategies and translational limitations.

• Tunable Human Intestinal Organoids: Study Insights

  2026-09-01

  The reference study develops a human small-intestinal organoid system that maintains strong proliferation while expanding epithelial cell diversity under a single culture condition. Its small-molecule strategy also enables reversible or directional control of lineage output, offering a more scalable framework for intestinal development, disease modeling, and screening.

• Diuron Workflows for Plant and Renal Toxicology

  2026-08-31

  Diuron supports two distinct research use cases: controlled photosynthesis-inhibition assays in plant systems and mechanistic toxicology studies in HK-2 renal cells. This workflow-focused guide connects solvent handling, dose-response design, JAK2/STAT1 validation, and troubleshooting for more reproducible results.

• Imipenem P10075 for Reliable Cell Assays

  2026-08-30

  This scenario-driven guide explains how Imipenem, SKU P10075, can support controlled antibacterial, immune-response, and cell-based assay workflows. It covers mechanism, aqueous formulation, concentration selection, resistance-aware interpretation, and practical supplier evaluation using product data and recent resistance epidemiology.

• Reserpine (N1867): Practical Lab Workflow

  2026-08-29

  Reserpine (SKU N1867) provides a characterized, high-purity small-molecule reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. Its water and ethanol insolubility, DMSO-based preparation requirements, and potent biological activity make it unsuitable for diagnostic or medical use and require fresh, assay-validated solutions.

• Caspase-8 Activity in Combination Cancer Therapy

  2026-08-29

  Caspase-8 is more than an apoptosis marker: it is a catalytic decision point linking treatment stress to apoptosis and pyroptosis. This thought-leadership guide translates recent hyperthermia–cisplatin findings into a practical strategy for validating caspase-8 activity with an IETD-AFC fluorometric workflow.

• Neticonazole Hydrochloride: Bench-to-Model Guide

  2026-08-28

  Neticonazole Hydrochloride connects a validated topical imidazole antifungal use-case with an emerging colorectal cancer research hypothesis involving exosome suppression and apoptosis induction via Bcl-2/Bax regulation. This practical guide shows how to prepare the compound, build assay controls, distinguish antifungal activity from nonspecific cytotoxicity, and troubleshoot reproducibility.

• NSP15 Natural-Product Screening: Thymopentin and Oleuropein

  2026-08-28

  Vijayan and Gourinath used structure-based virtual screening and molecular dynamics to prioritize natural products that may inhibit the SARS-CoV-2 NSP15 endoribonuclease. Thymopentin and oleuropein produced the most favorable computational profiles, but their status as antiviral leads remains to be established by biochemical, cellular, and in vivo experiments.

• Shufeng Xingbi Therapy in Allergic Rhinitis Rats

  2026-08-27

  This bioRxiv preprint examines how Shufeng Xingbi Therapy affects allergic rhinitis in OVA-sensitized rats by integrating nasal inflammation, Th1/Th2-associated signaling, gut microbiota, and short-chain fatty acids. The findings support a microbiota–immune relationship, while the preclinical design and lack of peer review require cautious interpretation before translation to human allergic rhinitis.

• Mubritinib (TAK 165) Complex I Research Guide

  2026-08-27

  Mubritinib (TAK 165) enables mechanism-first studies of mitochondrial complex I dependence in chemotherapy-resistant AML and KSHV-positive PEL models. This practical guide combines concentration selection, orthogonal metabolic readouts, albumin-binding considerations, and troubleshooting for more interpretable cancer biology data.

• CFDA SE Cell Tracer Kit: Practical Guide

  2026-08-26

  The CFDA SE Cell Tracer Kit provides stable fluorescent labeling for monitoring cell proliferation, cell location, and lineage-related behavior over several days. It is intended for persistent covalent labeling rather than reversible, transient, or rapid-clearance staining workflows.

455 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page